Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
5750-76-5Clc1ncc(Cl)c(Cl)n1GIKMWFAAEIACRF-UHFFFAOYSA-N5750-76-5DTXSID50206116CHEMBL1979246Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
This chemical does not meet GHS hazard criteria for 3.4% (2 of 58) of reports.
Danger
H314 (10.3%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation];H315 (86.2%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (86.2%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (84.5%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
P260, P261, P264, P264+P265, P271, P280, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P351+P338, P305+P354+P338, P316, P319, P321, P332+P317, P337+P317, P362+P364, P363, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 58 reports by companies from 12 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Reported as not meeting GHS hazard criteria per 2 of 58 reports by companies.;There are 11 notifications provided by 56 of 58 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Verwenden2,4,5-Trichloropyrimidine is used in the synthesis of potent and selective anaplastic lymphoma kinase (ALK-5) inhibitors, used as an anti-tumor treatment. Also used in the synthesis of EGFR inhibitors.
Wird geladen…